Targeting Inflammation in Both ALS and Alzheimer's Disease
Mark Albers, MD, PhD, from Massachusetts General Hospital, discovered a new mechanism that damages nerve cells and triggers an inflammatory response in both ALS and Alzheimer's patients.
Safe Care CommitmentGet the care you need even during COVID-19.Learn more
Mark W. Albers is a neurologist specializing in memory and olfactory disorders. He earned a PhD in organic chemistry from Harvard University, working in the laboratory of Stuart Schreiber, and an MD degree from the H.S.T. program of Harvard Medical School and M.I.T. He was an internal medicine resident for two years at Massachusetts General Hospital and then trained in neurology at Mass General, and Brigham and Women's Hospital, where he was one of the first chief residents for the Mass General Brigham neurology residency program. Following clinical training, he resumed basic research studies in the laboratory of Richard Axel and practiced behavioral neurology in the Memory Disorders Center at the Neurological Institute, affiliated with Columbia University. Following this training, he returned to Mass General where he sees outpatients in the Memory Disorders Unit and attends on the inpatient neurologic wards. His clinical research is focused on devising sensitive probes of olfactory function as a possible biomarker for early neurodegenerative disease and directly converting olfactory neuronal precursor cells from the nose into brain neurons to develop cell-based models of neurologic disease. He is a member of the Translational Neuroscience committee of the American Academy of Neurology.
Clinical Interests:
Treats:
Neurology Associates
15 Parkman Street
Boston, MA 02114-3117
Phone: 617-726-1728
Fax: 617-724-1480
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
The goal of the research in the Albers lab is to elucidate the pathogenic actions and physiological functions of genes implicated in neurodegenerative disease.
Read more about the Albers Lab.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.
The McCance Center for Brain Health has embraced a radically new approach to preventing brain disease and promoting brain health across the lifespan.
Mark Albers, MD, PhD, from Massachusetts General Hospital, discovered a new mechanism that damages nerve cells and triggers an inflammatory response in both ALS and Alzheimer's patients.
Mark Albers, MD, PhD, is developing a set of simple but powerful tools to screen for the very earliest stages of preclinical Alzheimer’s Disease.